Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedEnrollment status updated to no longer recruiting, affecting participant access and study enrollment. The page also added new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated labels and revision tag (v3.6.0) alongside a formatting change for Intervention/Treatment.SummaryDifference0.3%

- Check8 days agoChange DetectedA new revision tag (Revision: v3.5.5) was added, replacing the previous v3.5.4, indicating an updated version of the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows Revision: v3.5.4 instead of the previous v3.5.3. This indicates an updated release/version identifier for the page rather than a substantive content change.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s footer software/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than content changes to the clinical study information.SummaryDifference0.0%

- Check58 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision update added: v3.5.0. Revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.